Category: Top Story

  • Caribou Biosciences Shares Double After Strong Multiple Myeloma Trial Results

    Caribou Biosciences Shares Double After Strong Multiple Myeloma Trial Results

    Caribou Biosciences Inc. (NASDAQ:CRBU) shares skyrocketed 100% on Monday after the company released promising Phase 1 clinical data for its CB-011 therapy in patients with relapsed or refractory multiple myeloma. The CRISPR-based genome-editing company reported a 92% overall response rate and a 75% complete response rate or better among 12 patients treated with the recommended…

  • Stardust Power Shares Jump 15% After Securing Long-Term U.S. Lithium Supply Deal

    Stardust Power Shares Jump 15% After Securing Long-Term U.S. Lithium Supply Deal

    Stardust Power Inc. (NASDAQ:SDST) shares soared 15% on Monday after the company announced a strategic supply agreement with Mandrake Resources Limited, ensuring access to 7,500 metric tons per year of lithium chloride from Mandrake’s Utah Lithium Project. The companies signed a non-binding Letter of Intent outlining a 12-year supply arrangement with an optional six-year extension,…

  • BioNTech Shares Climb as Strong Revenue Growth Offsets Profit Miss

    BioNTech Shares Climb as Strong Revenue Growth Offsets Profit Miss

    BioNTech SE (NASDAQ:BNTX) shares rose 2.9% on Monday after the German biotech firm reported third-quarter revenue that far exceeded expectations, even though it posted a loss where analysts had forecast a profit. The company also raised its full-year 2025 revenue outlook, citing stronger-than-expected results from its collaboration with Bristol Myers Squibb (NYSE:BMY). For the third…

  • Kenvue Shares Soar 22% After $48.7 Billion Merger Deal With Kimberly-Clark

    Kenvue Shares Soar 22% After $48.7 Billion Merger Deal With Kimberly-Clark

    Kenvue (NYSE:KVUE) shares surged more than 22% in premarket trading Monday after the U.S. consumer health company reported better-than-expected third-quarter results and revealed plans to be acquired by Kimberly-Clark (NASDAQ:KMB) in a $48.7 billion cash-and-stock deal. For the third quarter, Kenvue earned $0.28 per share, topping analyst estimates of $0.26, while revenue came in at…

  • Kimberly-Clark Shares Drop as $48.7 Billion Kenvue Acquisition Sparks Legal Concerns

    Kimberly-Clark Shares Drop as $48.7 Billion Kenvue Acquisition Sparks Legal Concerns

    Kimberly-Clark (NASDAQ:KMB) shares tumbled more than 13% on Monday after the company announced a major cash-and-stock acquisition of Kenvue (NYSE:KVUE), valuing the consumer health firm at an enterprise value of roughly $48.7 billion. Under the agreement, Kenvue shareholders will receive $3.50 per share in cash and 0.14625 shares of Kimberly-Clark for each Kenvue share held.…

  • Freshpet Shares Surge After Q3 Earnings Blow Past Expectations

    Freshpet Shares Surge After Q3 Earnings Blow Past Expectations

    Freshpet, Inc. (NASDAQ:FRPT) shares climbed 5.3% on Monday after the pet food company reported third-quarter results that sharply outperformed Wall Street estimates, supported by robust sales growth and improved profitability. The company posted adjusted earnings of $1.86 per share, far exceeding the consensus forecast of $0.43. Revenue rose 14% year-on-year to $288.8 million, topping analyst…

  • uniQure Shares Collapse 75% After FDA Reverses Position on Huntington’s Therapy

    uniQure Shares Collapse 75% After FDA Reverses Position on Huntington’s Therapy

    uniQure N.V. (NASDAQ:QURE) shares plunged 75% on Monday after the biotech company announced a major regulatory setback for its experimental Huntington’s disease gene therapy, AMT-130. The Netherlands-based firm revealed that the U.S. Food and Drug Administration (FDA) no longer agrees that data from Phase I/II trials, when compared with external control datasets, would be sufficient…

  • Beyond Meat Delays Q3 Earnings Release to Complete Impairment Review

    Beyond Meat Delays Q3 Earnings Release to Complete Impairment Review

    Beyond Meat (NASDAQ:BYND) has delayed the release of its third-quarter financial results to November 11, citing the need for additional time to finalize an accounting review. The company said it is assessing a material non-cash impairment charge tied to certain long-lived assets. The plant-based meat company explained that it requires more time and resources to…

  • IREN Shares Soar on $9.7 Billion AI Cloud Partnership with Microsoft

    IREN Shares Soar on $9.7 Billion AI Cloud Partnership with Microsoft

    IREN Limited (NASDAQ:IREN) surged more than 24% in premarket trading Monday after announcing a five-year GPU cloud services deal with Microsoft (NASDAQ:MSFT) valued at approximately $9.7 billion, marking one of the largest AI infrastructure partnerships in recent months. As part of the agreement, IREN will supply Microsoft with access to NVIDIA (NASDAQ:NVDA) GB300 GPUs, with…

  • Five Market Themes to Watch in the Coming Week

    Five Market Themes to Watch in the Coming Week

    The trading week ahead begins under the shadow of a prolonged U.S. government shutdown, which continues to delay key economic reports, including the crucial nonfarm payrolls data. Meanwhile, the U.S. Supreme Court is set to hear arguments on the legality of former President Donald Trump’s sweeping tariffs, while investors await quarterly results from Advanced Micro…